A dose escalating study of cabazitaxel (XRP6258) in combination with capecitabine, in patients (pts) with metastatic breast cancer (MBC) progressing after anthracycline and taxane therapy

被引：1
|
作者：
Villanueva, C. [1 ]
Awada, A. [2 ]
Campone, M. [3 ]
Machiels, J. P. [4 ]
Besse, T. [2 ]
Magherini, E. [5 ]
Dubin, F. [5 ]
Semiond, D. [5 ]
Pivot, X. [1 ]
机构：
[1] Hop Jean Minjoz, F-25030 Besancon, France
[2] Inst Jules Bordet, B-1000 Brussels, Belgium
[3] Ctr Rene Gauducheau, F-44035 Nantes, France
[4] Clin Univ St Luc, Ctr Canc, B-1200 Brussels, Belgium
[5] Sanofi Aventis, Paris, France
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)70917-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：268 / 268
页数：1
相关论文
共 50 条
  • [1] A dose-escalating study of XRP6258 in combination with capecitabine, in patients (pts) with metastatic breast cancer (MBC) progressing after anthracycline and taxane therapy: Preliminary results
    Besse-Hammer, T.
    Villanueva, C.
    Campone, M.
    Machiels, J.
    Awada, A.
    Magherini, E.
    Dubin, F.
    Semiond, D.
    Pivot, X. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [2] A multicentre dose-escalating study of cabazitaxel (XRP6258) in combination with capecitabine in patients with metastatic breast cancer progressing after anthracycline and taxane treatment: A phase I/II study
    Villanueva, C.
    Awada, A.
    Campone, M.
    Machiels, J. P.
    Besse, T.
    Magherini, E.
    Dubin, F.
    Semiond, D.
    Pivot, X.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (07) : 1037 - 1045
  • [3] Multicenter phase 2 study of XRP6258 in taxane-resistant metastatic breast cancer (MBC) patients (pts).
    Pivot, X
    Koralewski, P
    Hidalgo, JL
    Chan, A
    Viens, P
    Schwartsmann, G
    Brunel, E
    Ramazeilles, C
    Assadourian, S
    Lotz, JP
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S68 - S68
  • [4] Ixabepilone in patients (PTS) with metastatic breast cancer (MBC) that is resistant to an anthracycline, a taxane and capecitabine
    Pivot, Xavier
    Thomas, Eva
    Lerzo, Guillermo
    Bosserman, Linda
    Vahdat, Linda
    Cai, Can
    Mullaney, Brian
    Viens, Patrice
    Perez, Edith
    Hortobagyi, Gabriel N.
    ANNALS OF ONCOLOGY, 2006, 17 : 70 - 71
  • [5] Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment
    Thomas, Eva S.
    Gomez, Henry L.
    Li, Rubi K.
    Chung, Hyun-Cheol
    Fein, Luis E.
    Chan, Valorie F.
    Jassem, Jacek
    Pivot, Xavier B.
    Klimovsky, Judith V.
    de Mendoza, Fernando Hurtado
    Xu, Binghe
    Campone, Mario
    Lerzo, Guillermo L.
    Peck, Ronald A.
    Mukhopadhyay, Pralay
    Vahdat, Linda T.
    Roche, Henri H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (33) : 5210 - 5217
  • [6] Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment
    Thomas, Eva S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (13) : 2223 - 2223
  • [7] Ixabepilone plus capecitabine for Chinese patients with metastatic breast cancer progressing after anthracycline and taxane treatment
    Wang, Jiayu
    Fan, Ying
    Xu, Binghe
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (03) : 597 - 603
  • [8] Ixabepilone plus capecitabine for Chinese patients with metastatic breast cancer progressing after anthracycline and taxane treatment
    Jiayu Wang
    Ying Fan
    Binghe Xu
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 597 - 603
  • [9] MULTICENTER, PHASE II STUDY OF LAROTAXEL IN PATIENTS (PTS) WITH METASTATIC BREAST CANCER (MBC) PROGRESSING AFTER ANTHRACYCLINES, TAXANES AND CAPECITABINE
    Ozguroglu, M.
    Mansutti, M.
    Kerr, R.
    Awada, A.
    Rha, S. Y.
    Im, Y. H.
    Perez Manga, G.
    Germann, N.
    Fumoleau, P.
    ANNALS OF ONCOLOGY, 2008, 19 : 69 - 69
  • [10] Capecitabine and cisplatin combination is an active and well-tolerated doublet in the treatment of metastatic breast cancer progressing after anthracycline and taxane
    Ozdemir, Nuriye Yildirim
    Abali, Huseyin
    Oksuzoglu, Berna
    Budakoglu, Burcin
    Uncu, Dogan
    Guler, Tunc
    Zengin, Nurullah
    Hastanesi, Ankara Numune
    ANNALS OF ONCOLOGY, 2006, 17 : 86 - 86
12345